Nagase Viita to Launch Injectable-grade Pharmaceutical Excipient “SUCROSE SG” in 2025
19 Novembre 2024 | adnkronos
OKAYAMA, Japan, Nov. 19, 2024 /PRNewswire/ — Nagase Viita Co., Ltd., a member of the NAGASE Group headquartered in Okayama Japan, is set to expand the line of SOLBIOTE (TM), saccharide-based pharmaceutical excipients, with the launch of high-purity and low-endotoxin SUCROSE SG by June 2025….